CVE detail

CVE-2024-2275 — CVE-2024-2275

Published 2024-03-08 · Modified 2026-06-17 · Vendor bdtask · Product g-prescription_gynaecology_\&_obs_consultation · Source nvd
LOW
severity
CVSS-derived band
2.4
CVSS v3
0–10 scale
0.0045
EPSS probability
exploitation probability, 30d
37.0%
EPSS percentile
percentile vs all CVEs
NOT LISTED
CISA KEV
known exploited catalog

Description

A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.